ArticleAging clinical and experimental research2026
Immunological impact of age and comorbidities: findings from the REALISM and SENIOR-HLA-DR cohorts.
Article in Aging clinical and experimental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe ageing population faces numerous physiological changes, among which immunosenescence plays a central role. Understanding the mechanisms underlying immunosenescence remains a priority. Within this framework, the contribution of comorbidities to immune dysfunction is still poorly characterized, despite growing evidence suggesting that it may represent a critical determinant in the evaluation of immunosenescence. The main objective of this report was to disentangle the respective impacts of age and comorbidities. To this end, we focused on immunological parameters originally developed in the context of sepsis, a condition that shares many immunological defects with immunosenescence.
methodsData were obtained from two cohorts: the REALISM cohort, including healthy elderly individuals, and the SENIOR-HLA-DR cohort, consisting of a real-life hospitalized geriatric population. Immunological parameters assessed were circulating IL-6, percentage of immature neutrophils, monocyte HLA-DR expression (mHLA-DR), neutrophil-to-lymphocyte ratio (NLR), T lymphocyte count, and interferon-γ release assay (IGRA) in response to phytohemagglutinin (PHA).
resultsIn the absence of comorbidities, age had no detectable effect on immune parameters in the REALISM cohort (n = 174 individuals). The SENIOR-HLA-DR cohort (n = 76 patients) revealed that cardiovascular comorbidities exerted the greatest influence, being associated with significantly reduced mHLA-DR expression and increased NLR. Infections further triggered substantial alterations in inflammation and innate immunity, characterized by elevated percentages of immature neutrophils and decreased mHLA-DR expression. DISCUSSION-
conclusionsOur findings indicate a limited impact of chronological age and comorbidities on the selected immunological parameters. These results suggest that routine clinical tools may be insufficient to fully capture the complexity of immunosenescence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.